The substantiation of the conceptual model for countering the spread and combating counterfeit medicines and medical products in Ukraine

Authors

DOI:

https://doi.org/10.24959/sphhcj.21.241

Keywords:

conceptual model; combating counterfeit; medicines; medical devices.

Abstract

The problem of drug counterfeiting is global; therefore, it is relevant for all countries of the world. However, the effectiveness combating the spread of counterfeit medicines (CM) differs in different countries, as evidenced by data on the level of counterfeit. Ensuring proper quality control of drugs in all areas of their circulation requires national regulatory authorities to systematically address these urgent problems; primarily, this concerns the pharmaceutical legislation to counteract the spread of counterfeit medicines and medical devices (MD), as well as to implement the effective state policy in this extremely important area that determines the national security of the state.

References

References

KM Ukrainy. (2019). Rozporiadzhennia vid 03.04.2019 No. 301-r. “Pro skhvalennia Kontseptsii realizatsii derzhavnoi polityky shchodo zapobihannia falsyfikatsii likarskykh zasobiv ta zatverdzhennia planu zakhodiv z yii realizatsii”. zakon.rada.gov.ua. Available at: https://zakon.rada.gov.ua/laws/show/301-2019-%D1%80#Text

Houlton, S. (2018). Tackling the problem of falsified medicines in the UK. Prescriber, 29 (7), 33-35. doi: https://doi.org/10.1002/psb.1690.

Schneider, M., Ho Tu Nam, N. (2020). Africa and counterfeit pharmaceuticals in the times of COVID-19. Journal of Intellectual Property Law & Practice, 15 (6). doi: https://doi.org/10.1093/jiplp/jpaa073.

Funestrand, H., Liu, R., Lundin, S., Troein, M. (2019). Substandard and falsified medical products are a global public health threat. A pilot survey of awareness among physicians in Sweden. J. Public. Health (Oxf), 41 (1), e95–e102. doi: https://doi.org/10.1093/pubmed/fdy092.

Ciapponi, A., Donato, M., Gulmezoglu, A., Alconada, T., Bardach, A. (2021). Mobile apps for detecting falsified and substandard drugs: A systematic review. Plos one, 16 (2), e0246061. doi: https://doi.org/10.1371/journal.pone.0246061.

Soloviov, O. S. (2019). Konventsiia “Medikrym” yak instrument protydii pidroblenniu medychnoi produktsii v Ukraini. Sotsialna farmatsiia v okhoroni zdorov’ia, 5 (3), 57–64. doi: https://doi.org/10.24959/sphhcj.19.158.

Sur, S. (2021). Creation, development and decline of the anti-counterfeiting system in Ukraine. Shchotyzhnevyk Apteka, 3. Available at: https://www.apteka.ua/article/581247.

Gutorova, N. (2019) Responsibility for falsification of medicines: has a proper legal framework been created in Ukraine? Shchotyzhnevyk Apteka, 2. Available at: https://www.apteka.ua/article/485029.

Shmatenko, O. P., Holub, А. H., Rudenko, V. V., Takhtaulova, N. O., Rumiantsev, Yu. V. (2018). Viiskova medytsyna Ukrainy, 18 (3), 86-90.

Counterfeit drugs 2021: Statistics and Facts on how Blockchain can fight the pandemic? (2021). vaultsecurity.io. Available at: https://vaultsecurity.io/counterfeit-drugs-2021.

Vsesvitnia orhanizatsiia okhorony zdorovia. Vykonavchyi Komitet. (2017). Mekhanizm derzhav-chleniv shchodo nekondytsiinoi/pidroblenoi/khybno markovanoi/falsyfikovanoi/kontrafaktnoi medychnoi produktsii: proekt rishennia No. EB140/23. Available at: https://apps.who.int/iris/handle/10665/273269.

Chitre, M., Sapkal, S., Adhikari A., Mulla, S. (2019). Monitoring Counterfeit Drugs using CounterChain. International Conference on Advances in Computing, Communication and Control (ICAC3). (pp. 1–6). doi: https://doi.org/10.1109/ICAC347590.2019.9036794.

Galt, K., Fuji, K., Kaufman, T. Shah S. (2019). Health information technology use and patient safety: study of pharmacists in Nebraska. Pharmacy, 7 (1), 1-7. DOI: https://doi.org/10.3390/pharmacy7010007.

Nemchenko, A., Lebed, S. (2020). Sotsialna farmatsiia v okhoroni zdorovia, 6 (3), 34-40. doi: https://doi.org/10.24959/sphhcj.20.190.

Lebed, S., Nemchenko, A. (2021). Problems of false medicines’ distribution and prospects of combat: survey of specialists and consumers results. ScienceRise: Pharmaceutical Science, 5 (33), 49–56. doi: https://doi.org/10.15587/2519-4852.2021.243240.

Downloads

Published

2021-12-24

Issue

Vol. 7 No. 4 (2021)

Section

Organizational and socio-economic bases of pharmaceutical activities

License

Copyright (c) 2021 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).